Vaccines List

Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...

Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). GUCY2C, a paracrine hormone receptor producing the second messenger cyclic GMP (cGMP), is selectively expressed by intestinal epithelial cells and a subset of hypothalamic neurons, but not other tissues. Read more...

Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Adacel vaccine does not contain preservatives.Read more...

Afluria is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.Read more...

ASP3772 utilizes the Multiple Antigen Presenting System (MAPS) platform which is Affinivax’s proprietary, next-generation vaccine technology. MAPS uniquely presents key epitopes of the desired antigens (polysaccharides and/or proteins) to induce a robust and broad immune response against challenging diseases.Read more...

AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...

Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...

BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...

Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria. The inactive ingredients in the vaccine are aluminium hydroxide, aluminium phosphate, formaldehyde, polysorbate 80, sodium chloride (salt), glycine and water.Read more...

BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...

Chikungunya Virus virus-like particle (CHIKV-VLP) vaccines are multi-protein structures that mimic the organization and conformation of naturally occurring viruses, without the viral genome, that could potentially promote a stronger immune response and increased antibody production.Read more...

CRV-101 is a next-generation vaccine designed to maximize the CMI protection by combining the gE protein antigen with our proprietary adjuvantRead more...

Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...

Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...

Dengvaxia is a live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM (pre-membrane) and E (envelope) structural genes of yellow fever attenuated 17D strain vaccine with those from the four dengue serotypes.Read more...

Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...

Merck's Ervebo V920 (VSV-EBOV) is a recombinant, replication-competent Ebola vaccine, consisting of a vesicular stomatitis virus (VSV), which has been genetically engineered to express a glycoprotein from the Zaire ebolavirus so as to provoke a neutralizing immune response to the Ebola virus.Read more...

FLU-v is a novel peptide vaccine candidate.Read more...

Fluarix Quadrivalent is prepared from influenza viruses propagated in embryonated chicken eggs. Each of the influenza viruses is produced and purified separately. After harvesting the virus-containing fluids, each influenza virus is concentrated and purified by zonal centrifugation using a linear sucrose density gradient solution containing detergent to disrupt the viruses. Following dilution, the vaccine is further purified by diafiltration.Read more...

Flucelvax Quadrivalent is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...

FluMist Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine that is formulated to contain four vaccine virus strains, for 2018-2019, an A/H1N1 strain, and A/H3N2 strain, and two B strains, the B/Yamagata/16/88 and B/Victoria/2/87 lineages.Read more...

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Fluzone Intradermal Quadrivalent is a vaccine that consists of the 4 influenza strains that have been identified for the current flu season.Read more...

Gardasil consists of 4 proteins of HPV Types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...

GBS6 is a multivalent group B streptococcus vaccine candidateRead more...

GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...

GI.1/GII.4 is a tablet oral norovirus vaccine consisting of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN.  Read more...

Havrix is a sterile suspension of inactivated virus strain HM175 which is propagated in MRC-5 human diploid cells. After removal of the cell culture medium, the cells are lysed to form a suspension. This suspension is purified through ultrafiltration and gel permeation chromatography procedures. Treatment of this lysate with formalin ensures viral inactivation.Read more...

Hecolin is a recombinant vaccine which contains the hepatitis E virus (HEV)-like particles prepared using a recombinant Escherichia coli expression systemRead more...

HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...

HydroVax-001 is a vaccine candidate which consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...

Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...

Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.Read more...

INO-4500 is a DNA-encoded monoclonal antibody (dMAb™) immunotherapy vaccine candidate.Read more...

IVX-121 an RSV vaccine candidate incorporates a stabilized prefusion F antigen licensed from NIAID/NIHRead more...

Kinrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria as well as Inactivated Poliovirus Vaccine.Read more...

mAb114 is a human IgG1 MAb targeted to the Zaire ebolavirus (EBOV) glycoprotein (GP).  mAb114 is a single monoclonal antibody which binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cellsRead more...

Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...

M-M-R II is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine, containing weakened forms of measles virus, mumps virus, and rubella virus.Read more...

Mosquirix (RTS,S/AS01) is a recombinant vaccine consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

Multimeric-001 (M-001) is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...

NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.Read more...

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

Niprab, a pre-clinical vaccine candidate, is a novel recombinant vaccine that uses a modified rabies virus vector and incorporates a gene from Nipah virus Read more...

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

PennVax-GP has been optimized to target two env antigens, as well as gag and pol antigens. This comprehensive targeting gives PennVax-GP the potential to provide global coverage against HIV-1 subtypesRead more...

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component Read more...

PF-04965842 is an oral small molecule vaccine candidate that selectively inhibits Janus kinase (JAK) 1.Read more...

Pneumovax 23 vaccine contains 23 serotypes (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F).Read more...

Prevnar 13 is a sterile suspension of saccharides of the capsular antigens of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, individually linked to non-toxic diphtheria CRM197 protein. Read more...

Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...

ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) is a combined, attenuated, live virus vaccine containing measles, mumps, rubella, and varicella viruses.Read more...

Provenge active components are autologous antigen-presenting cells (APCs) and the protein called PAP-GM-CSF.

APCs are activated during a defined culture period with a recombinant human protein, PAP-GM-CSF, consisting of prostatic acid phosphatase (PAP), an antigen expressed in prostate cancer tissue, linked to granulocyte-macrophage colony-stimulating factor (GM‑CSF), an immune cell activator.Read more...

PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface proteins, CD32B and CD79B, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) and other B cell-mediated autoimmune diseases.Read more...

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

Quadracel  vaccine contains diphtheria toxoid, tetanus toxoid, acellular pertussis [pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM)], inactivated poliomyelitis vaccine (IPV) type 1 (Mahoney), type 2 (MEF-1) and type 3 (Saukett)].Read more...

Recombivax HB consists of each 1 mL contains 10 µg hepatitis B surface antigenRead more...

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...

RiVax is a safe alum-adjuvanted subunit vaccine candidate which may prevent death and injury from any route of exposure to ricin toxin.Read more...

RotaTeq is a live, oral pentavalent vaccine that contains 5 reassortant viruses.Read more...

Sci-B-Vac is a licensed, third-generation hepatitis B  trivalent vaccine which mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...

scMAYV-E is a novel DNA vaccine that encodes a synthetically-designed consensus MAYV envelope sequence.Read more...

Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus1 17D-204 strain produced in specified pathogen-free chick embryos.Read more...

TAK-003 is an investigational live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus. Read more...

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

TG4050 is an individualized MVA-based immunotherapy designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

TMCP2 is a vaccine candidate to treat Gonorrhea. It is a complex peptide that is both scalable and economically produced to a high degree of purity.Read more...

Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...

TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...

Typhim VI is a sterile solution, prepared from the purified polysaccharide capsule of Salmonella typhi (Ty 2 strain).Read more...

V114 consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33F, which are commonly associated with invasive pneumococcal disease (IPD) worldwide.Read more...

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Vaxchora is a live attenuated recombinant V. cholerae O1 Inaba Vaccine Strain CVD 103-HgR, which is able to synthesize the immunogenic nontoxic B subunit of CT (encoded by the ctxB gene).Read more...

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

VBI-1901 is a polyvalent therapeutic vaccine candidate designed to direct an immune response against gB and pp65, two CMV antigens that are highly immunogenic targets during natural infection. Read more...

VCL-HB01 is a therapeutic HSV plasmid DNA vaccine candidate formulated with Vaxfectin.Read more...

Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...

VLA1553 is a monovalent, single dose, live-attenuated vaccine candidate.Read more...

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...